Please login to the form below
pharma meeting
This page shows the latest pharma meeting news and features for those working in and with pharma, biotech and healthcare.
Lexicon Pharma announces strong CV data for first-in-class sotagliflozin at the European Society of Cardiology’s annual meeting
US-based Lexicon Pharmaceuticals has announced further analyses on the cardiovascular benefits of its first-in-class candidate, sotagliflozin, at the European Society of Cardiology annual meeting.
Latest news
-
Stakeholder meeting kick-starts dialogue on COVID-19 vaccine supply chain issues
The meeting, which took place on 8-9 March, aimed to ‘open dialogue’ around the issues currently surrounding COVID-19 vaccine manufacturing. ... The meeting participants discussed potential solutions to these issues, citing a number of measures to
-
FDA schedules meeting on 26 February to review J&J’s one-dose COVID-19 vaccine
The US Food and Drug Administration (FDA) has scheduled a meeting of an expert advisory committee to discuss the emergence use authorisation for Johnson &Johnson’s (J&J) one-dose
-
In virtual meeting, CHMP backs Sanofi’s myeloma drug Sarclisa
Monthly meeting held remotely for the first time due to COVID-19 pandemic. ... The first piece of news to come out of the monthly meeting of the EMA’s human drugs advisory committee – held remotely for the first time – is a green light for
-
Modest meeting sees only two drugs recommended by CHMP
one generic medicine at its latest meeting, with a surprise negative opinion for Eli Lilly’s migraine med Emgality. ... The CHMP recommended a marketing authorisation of Japanese pharma company Shionogi’s antimicrobial drug Fetcroja (cefiderocol) for
-
HIV meeting hears progress towards vaccine and cure
vaccine discovery and translational medicine at J&J’s Janssen pharma unit.
More from news
Approximately 0 fully matching, plus 36 partially matching documents found.
Latest Intelligence
-
Scientific meetings: leveraging on-site, virtual, on-demand and enduring materials
80% valued independent meeting portals supported by pharma. 90% said being able to access information beyond the physical meeting helped them to apply new medical approaches more quickly. ... The benefits for time-poor HCPs are clear, and for pharma
-
Pharma: in search of the sustainable ‘win win’ with the NHS
But how can the pharma industry engage with these new models of care? ... I’ll be chairing Pharma Market Europe and IQVIA’s roundtable next week tackling this central question:.
-
Rare diseases: meeting the challenge
In other words, there are significant gaps - and this is where pharma manufacturers come in. ... is a freelance writer specialising in reports and features for the health and pharma industry.
-
A digital strategy in a digital world
Pharma has to figure how to engage with it.”. The route to bridging the chasm between pharma and physicians seems to lie in relationship building; with pharma understanding - and then meeting - ... This is the key message for pharma: it must segment
-
Deal Watch October 2016
Allergan, Astellas, AstraZeneca, Boehringer Ingelheim and Eli Lilly feature in this month's pharma deals round-up. ... Last month Deal Watch described the slow-down in the number of M&A and licensing deals reported by Evaluate at the European Pharma
More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.
Latest appointments
-
Roche's Silvia Ayyoubi retires
Silvia Ayyoubi is to step down as head of group human resources at Roche in the Swiss pharma firm's annual general meeting in March.
-
Merck KGaA adds two to its executive board
It will also see Bernd Reckmann, currently executive board member for life science and performance materials, retire at the German pharma firm's annual general meeting in April.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Top 10 Most Important Advisor Questions
I’m excited to share another Impetus top-10 list! This time, I focus on the top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints. Read the full blog article here.
-
From Vision to Action: Medical Affairs’ Time to Lead is Now – Key Themes and Takeaways From the 2022 Medical Affairs Professional Society (MAPS) Global Annual Meeting
Nucleus Global’s Luis Perez shares his thoughts on this year’s meeting. ... Their 2022 Global Annual Meeting included opportunities for networking with pharma/biotech stakeholders and solution vendors/partners and for fostering discussions about hot
-
Case Study: Reducing Travel-Related Emissions and Costs Through Virtual Events
In early 2021, due to COVID-19-related safety concerns and travel and social distancing restrictions, our client needed help to “virtualize” their nationwide, multi-day, multi-business unit internal event with 375 attendees. They wanted to avoid
-
Top 10 Reasons Why Virtual Collaboration and Medical Education Will Persist in the New Normal
A version of this article was previously published on Pharmaphorum. There is not a single industry that has been left untouched by COVID-19. While the effects of the pandemic have been devastating for many industries, its positive impact on
-
Top 10 Tips to Increase Engagement During Virtual Events
If you are a member of the Medical Affairs Professional Society (MAPS), you might have caught our popular webinar on how COVID-19 has impacted (and will continue to impact) live events. As part of this webinar, we discussed how engagement can be
More from PMHub
Approximately 6 fully matching, plus 6 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Biogen and Happify Health team up to create digital platform for MS patients
- MSD and AstraZeneca announce phase 3 results for prostate cancer therapy
- Moderna to launch Innovation and Technology Center in the UK
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Novo Nordisk and Echosens collaborate to advance early diagnosis of non-alcoholic steatohepatitis
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- NHS App to revolutionise digital health and care with major digital updates by 2023
- Dermavant publishes positive phase 3 data for treatment of plaque psoriasis
- How pharma found its voice – health communications for a brave new world
- The importance of beliefs in creative health engagement
- In recognition of the Anniversary of Stonewall, Nucleus Global brings attention and awareness to persistent health care inequities experienced by LGBTQIA+
- Novo Nordisk and Echosens collaborate to advance early diagnosis of non-alcoholic steatohepatitis
- MSD and AstraZeneca announce phase 3 results for prostate cancer therapy
- Almirall shares positive topline results from atopic dermatitis trials
- Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
- Pfizer to buy 8.1% stake in Valneva in support of joint Lyme disease programme
- Research from Imperial College London shows single brain scan could diagnose Alzheimer’s disease
Latest intelligence
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
- Report: Omnichannel advice for the life science industry
- In the latest issue of Delta magazine, Fishawack Health's Medical, Marketing, and Consulting experts share their practical advice for creating meaningful omnichannel stakeholder experiences and reveal our proprietary tool for...
